Skip to main content
. 2021 Apr 3;901:174082. doi: 10.1016/j.ejphar.2021.174082

Fig. 13.

Fig. 13

(A) The ten potential inhibitors against SARS-CoV-2 3CLPRO from FDA approved compounds, (B) Top 10 potential inhibitors bind to 3CLPRO protein near the long loop connected by domain-I and domain-II, (C) The surface protein with ligand bound to the pocket.